Haemophilus B Polysaccharide Conjugate (Diphtheria Toxoid Conjugate) Vaccine
Item Name Code (INC) 49435
Additional Information for Haemophilus B Polysaccharide Conjugate (Diphtheria Toxoid Conjugate) Vaccine
Haemophilus B Polysaccharide Conjugate (Diphtheria Toxoid Conjugate) Vaccine is a type of vaccine that helps protect against Haemophilus influenzae type b (Hib) infection. It is classified under the supply class Drugs And Biologicals in the supply group Medical, Dental, And Veterinary Equipment And Supplies.
Hib infection can cause serious illnesses such as meningitis, pneumonia, and other invasive diseases, especially in young children. The vaccine works by stimulating the immune system to produce antibodies against the Hib bacteria, providing immunity against future infections.
The vaccine is called a conjugate vaccine because it combines the Haemophilus B polysaccharide antigen with a diphtheria toxoid protein. This conjugation enhances the immune response and helps provide long-lasting protection.
Haemophilus B Polysaccharide Conjugate (Diphtheria Toxoid Conjugate) Vaccine is typically administered as a series of doses, starting in infancy and continuing through early childhood. It is considered a routine childhood vaccine and is often included in the recommended immunization schedule.
It is important to consult with a healthcare professional or refer to official guidelines to determine the specific dosage and schedule for administering this vaccine.
Related Item Names for INC 49435 Haemophilus B Polysaccharide Conjugate (Diphtheria Toxoid Conjugate) Vaccine
NATO Stock Numbers with Item Name 49435 Haemophilus B Polysaccharide Conjugate (Diphtheria Toxoid Conjugate) Vaccine Page 1 of 1
- NDC49281-0545-05
- RNCC: 3 | RNVC: 1 | DAC: 4
- J07CA02
- RNCC: 6 | RNVC: 9 | DAC: 9